Biocon Biologics to offer 15% stake to Serum Institute Life Sciences
Under the alliance, BBL will get committed access to 100 million doses of vaccines annually for 15 years and commercialisation rights of the SILS vaccine portfolio for global markets.from Markets-Economic Times https://ift.tt/3nTJ9BN
Post a Comment